KING OF PRUSSIA, Pa., April 7, 2021
The company’s Mental Health Map™ is the first of its kind and provides genetic predispositions with unique new insights and recommendations to help more people get started on their mental wellness journey.
Professional basketball player Kevin Love is continuing his public crusade advocating for mental health and wellness by partnering with Genomind®, a leading mental health company that has been working with mental health professionals for more than a decade. The company’s Professional PGx Express™ test evaluates variants of 24 genes, and is designed to help mental health providers select effective, well tolerated medications at the right doses in order to reduce the costly and potentially tragic trial and error that is so often seen with medications used for mental health.
More recently, Genomind introduced the Mental Health Map, a genetic test designed for people who are interested in their own mental health and wellness to get started on their journey. It is the expert starting point for understanding how you are predisposed to a variety of mental wellness traits and is available without a prescription.
Mental Health is a function of genetics, environment, lifestyle and experiences: that’s the Mental Health 360. After a year of shared anxiety and isolation, Genomind is bringing more comprehensive mental wellness understanding to all who want to better understand how they are hardwired and how they can address their genetic predispositions. Those who have taken the test have shown great engagement, with a high majority intending to continue their mental health journey.
The test shines a light on your genetic predispositions toward the 7 Core Genetic Mental Health Capabilities™: anxiety and stress, focus and memory, mood, sleep, social behavior, eating behavior and habits and substance use. The accompanying report and consultation with an advisor help you understand the impact of your unique genetic profile and provides extensive education and the tools you can use to build on strengths and overcome challenges.
“I’ve been very public about my own struggles with anxiety and depression in the hopes that by talking about it, I could help others come to terms with their own mental health issues and get the help they need. I’ve said it before and it’s even more true after the year we’ve had: Everyone is going through something that we can’t see. The first step is being open to help," said Love. "When I received my Mental Health Map results and reviewed them with a Genomind expert advisor, the first thing I noticed was the accuracy, based on knowing myself. It painted a thorough picture that made sense. And it's given me satisfaction knowing that I've been doing the right things for myself these past few years, but also provides an action plan to work on areas that need more attention."
“Our focus is to get more help to more people whether they are beginning their mental health journey or are already in treatment,” said Shawn O’Brien, Chairman & CEO of Genomind. “Many people don’t know this, but I came to Genomind as a concerned dad of a suicidal son. After witnessing how the Professional PGx Express Test literally helped save his life, I ultimately agreed to lead Genomind so I could help more people on this critical journey. I couldn’t be prouder to welcome Kevin to this noble fight. As we continue to talk about it and erase the stigma of mental health issues while educating people about the role genes play, we can make a huge difference together!”
The Genomind Mental Health map is available at www.mentalhealthmap.com or on Amazon. It retails for $599. The data collected in both tests remain private as Genomind is committed to not selling genetic or personal information.
Genomind is a leading precision mental health company singularly focused on filling the innovation gap in mental health care through novel, genetics-based tools. Supported by a world-class genetics lab, a unique heritage of clinical mental health expertise, clinical collaboration and consultation, state-of-the-art digital tools and tele-mental health enabling services, Genomind is empowering a new standard of care: Smarter Mental Healthcare. Its flagship product, Genomind® Professional PGx Express™, is the most comprehensive pharmacogenetic testing service helping medical professionals personalize patients’ mental health treatment. The company also recently launched Genomind® Mental Health Map™– a breakthrough direct-to-consumer test that enables a new and better understanding of the biological basis of mental wellness, coupled with personalized actionable guidance to help people improve health and wellness. Learn more at www.genomind.com.